SURGICAL ADJUVANT CHEMOTHERAPY OF METASTATIC MURINE OSTEO-SARCOMA

被引：13

作者：

HIRAMOTO, RN ^{[1
]}

GHANTA, VK ^{[1
]}

机构：

[1] UNIV ALABAMA,CTR COMPREHENS CANC,BIRMINGHAM,AL 35233

来源：

关键词：

D O I：

10.1002/ijc.2910250314

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：393 / 397

页数：5

共 15 条

[1] BARSKI G, 1974, ISRAEL J MED SCI, V10, P913
[2] DUNN TB, 1963, J NATL CANCER I, V31, P873
[3] FREI E, 1977, ADJUVANT THERAPY CAN, P49
[4] MONITORING OF MURINE OSTEOSARCOMA BY SERIAL ALKALINE-PHOSPHATASE DETERMINATIONS
GHANTA, VK
HIRAMOTO, RN
WEISS, AB
CAUDILL, L
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1976, 57 (04) : 837 - 839
[5] GHANTA VK, 1978, CLIN ORTHOP RELAT RE, V133, P245
[6] HIRAMOTO RN, 1977, CANCER RES, V37, P365
[7] MUGGIA FM, 1978, CANCER TREAT REP, V62, P301
[8] ROSEN G, 1978, CANCER-AM CANCER SOC, V41, P841, DOI 10.1002/1097-0142(197803)41:3<841::AID-CNCR2820410310>3.0.CO
[9] 2-Z
[10] SCHABEL FM, 1977, CANCER, V40, P558, DOI 10.1002/1097-0142(197707)40:1+<558::AID-CNCR2820400722>3.0.CO